home / stock / lnth / lnth news


LNTH News and Press, Lantheus Holdings Inc. From 03/17/23

Stock Information

Company Name: Lantheus Holdings Inc.
Stock Symbol: LNTH
Market: NASDAQ
Website: lantheus.com

Menu

LNTH LNTH Quote LNTH Short LNTH News LNTH Articles LNTH Message Board
Get LNTH Alerts

News, Short Squeeze, Breakout and More Instantly...

LNTH - Lantheus promotes internal candidate to President role

2023-03-17 08:48:20 ET Lantheus ( NASDAQ: LNTH ) announced that Paul Blanchfield has been promoted to President and Dan Niedzwiecki has been promoted to Chief Administrative Officer. Paul was instrumental in the successful launch of the company...

LNTH - Lantheus initiated at market outperform at JMP Securities on medtech growth

2023-03-08 12:11:38 ET JMP Securities has initiated Lantheus Holdings ( NASDAQ: LNTH ) with a market outperform rating saying the radiopharmaceuticals-focused company has "morphed into a MedTech growth leader with sustainability for years to come." The firm has a $120 pric...

LNTH - Why Shares of Lantheus Holdings Rose This Week

Shares of Lantheus Holdings (NASDAQ: LNTH) were up 21.2% for the week as of Friday afternoon, according to data provided by S&P Global Market Intelligence . The healthcare company released its quarterly results on Thursday, surpassing analysts' forecasts for revenue and e...

LNTH - Lantheus Holdings, Inc. (LNTH) Q4 2022 Earnings Call Transcript

Lantheus Holdings, Inc. (LNTH) Q4 2022 Earnings Conference Call February 23, 2023 08:00 AM ET Company Participants Mark Kinarney - Vice President of Investor Relations Mary Anne Heino - President & Chief Executive Officer Paul Blanchfield - Chief Operating Officer ...

LNTH - Lantheus stock rises ~15% on Q4 beat, while Wall Street cheers strong outlook

Lantheus ( NASDAQ: LNTH ) stock rose ~17% on Thursday after Q4 results beat estimates and the FY23 outlook was placed above expectations. Q4 adjuested EPS grew +448% Y/Y to $1.37, while revenues increased +103% to $263.17M. Both top and bottom line numbers surpassed analysts expec...

LNTH - Lantheus Holdings, Inc. 2022 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Lantheus Holdings, Inc. 2022 Q4 - Results - Earnings Call Presentation

LNTH - Lantheus Non-GAAP EPS of $1.37 beats by $0.41, revenue of $263.16M beats by $17.83M

Lantheus press release ( NASDAQ: LNTH ): Q4 Non-GAAP EPS of $1.37 beats by $0.41 . Revenue of $263.16M (+103.1% Y/Y) beats by $17.83M . 1Q23 Revenue between $280M-$285M vs consensus $256.47M. Adj. EPS between $1.28-$1.32 vs consensus of $1.06 FY23 Revenue between $...

LNTH - Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results

Worldwide revenue of $263.2 million and $935.1 million for the fourth quarter and full year 2022, representing increases of 103.1% and 119.9% over the prior year periods, respectively GAAP net loss of $119.2 million and GAAP net income of $28.1 million for the fourth quarter and full ye...

LNTH - Lantheus Q4 2022 Earnings Preview

Lantheus ( NASDAQ: LNTH ) is scheduled to announce Q4 earnings results on Thursday, February 23rd, before market open. The consensus EPS Estimate is $0.96 (compared to $0.25 in year ago quarter) and the consensus Revenue Estimate is $245.33M (+89.3% Y/Y). Over the last 2 years...

LNTH - Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels

BEDFORD, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, tod...

Previous 10 Next 10